Ayrmid Ltd.

Stories

Karyopharm files for bankruptcy to sell itself to Ayrmid

Lead bidder for Karyopharm's assets

Karyopharm Therapeutics filed for Chapter 11 bankruptcy on November 2, 2026, and agreed to sell itself to Ayrmid Ltd., the Irish parent of cell therapy maker Gamida Cell. Ayrmid is the lead bidder, not the guaranteed buyer: the filing sets up a court-supervised auction where other offers can compete.

Updated 1 hour ago